RGC vs. NVDA

Last updated Jun 13, 2026

RGC (Regencell Bioscience Holdings Limited) and NVDA (NVIDIA Corporation) are both stocks. RGC operates in Drug Manufacturers - Specialty & Generic (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 3 years, RGC returned -8.77%/yr vs 71.13%/yr for NVDA. At a 0.06 correlation, their price movements are largely independent.

Performance

RGC vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RGC achieves a -10.33% return, which is significantly lower than NVDA's 10.16% return.

RGC

• 1D: -4.37%
• 1M: -31.08%
• YTD: -10.33%
• 6M: 13.43%
• 1Y: -96.92%
• 3Y*: -8.77%
• 5Y*: —
• 10Y*: —

NVDA

• 1D: 0.16%
• 1M: -9.03%
• YTD: 10.16%
• 6M: 17.38%
• 1Y: 41.70%
• 3Y*: 71.13%
• 5Y*: 63.13%
• 10Y*: 67.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RGC vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RGC Regencell Bioscience Holdings Limited	-10.33%	325.10%	-52.95%	-62.35%	-12.43%	165.42%
NVDA NVIDIA Corporation	10.16%	38.92%	171.25%	239.02%	-50.26%	55.12%

Correlation

The correlation between RGC and NVDA is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.00
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021	0.06

Fundamentals

Market Cap RGC : $9.31B NVDA : $5.00T
EPS RGC : -$0.02 NVDA : $6.53
PB Ratio RGC : 7.64K NVDA : 25.60
Total Revenue (TTM) RGC : $0.00 NVDA : $253.49B
Gross Profit (TTM) RGC : -$40.84K NVDA : $187.95B
EBITDA (TTM) RGC : -$8.81M NVDA : $192.76B

Return for Risk

RGC vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC

RGC Risk / Return Rank: 19
RGC Sharpe Ratio Rank: 23
RGC Sortino Ratio Rank: 24
RGC Omega Ratio Rank: 22
RGC Calmar Ratio Rank: 2
RGC Martin Ratio Rank: 22

NVDA

NVDA Risk / Return Rank: 75
NVDA Sharpe Ratio Rank: 78
NVDA Sortino Ratio Rank: 73
NVDA Omega Ratio Rank: 71
NVDA Calmar Ratio Rank: 77
NVDA Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RGC	NVDA	Difference
Sharpe ratio: Return per unit of total volatility	-0.45	1.20	-1.65
Sortino ratio: Return per unit of downside risk	-0.36	1.75	-2.12
Omega ratio: Gain probability vs. loss probability	0.95	1.21	-0.27
Calmar ratio: Return relative to maximum drawdown	-0.99	2.07	-3.06
Martin ratio: Return relative to average drawdown	-1.01	4.94	-5.95

RGC vs. NVDA - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is -0.45, which is lower than the NVDA Sharpe Ratio of 1.20. The chart below compares the historical Sharpe Ratios of RGC and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RGC vs. NVDA - Drawdown Comparison

The maximum RGC drawdown since its inception was -98.82%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for RGC and NVDA.

Drawdown Indicators

	RGC	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-98.82%	-89.72%	-9.10%
Max Drawdown (1Y) Largest decline over 1 year	-98.26%	-20.21%	-78.05%
Max Drawdown (3Y) Largest decline over 3 years	-98.82%	-36.88%	-61.94%
Max Drawdown (5Y) Largest decline over 5 years	—	-66.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.34%	—
Current Drawdown Current decline from peak	-97.85%	-12.86%	-84.99%
Average Drawdown Average peak-to-trough decline	-64.69%	-36.18%	-28.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	96.08%	8.46%	+87.62%

Volatility

RGC vs. NVDA - Volatility Comparison

Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 19.08% compared to NVIDIA Corporation (NVDA) at 13.26%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RGC	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.08%	13.26%	+5.82%
Volatility (6M) Calculated over the trailing 6-month period	109.32%	26.67%	+82.65%
Volatility (1Y) Calculated over the trailing 1-year period	216.12%	35.00%	+181.12%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	283.47%	51.76%	+231.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	283.47%	49.84%	+233.63%

Dividends

RGC vs. NVDA - Dividend Comparison

RGC has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.14%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVDA NVIDIA Corporation	0.14%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%
RGC Regencell Bioscience Holdings Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both RGC and NVDA in my portfolio?

RGC and NVDA have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RGC or NVDA?

RGC has higher volatility (19.08%) compared to NVDA (13.26%). In terms of maximum drawdown, RGC dropped -98.82% vs NVDA's -89.72%.

Which has better risk-adjusted returns?

NVDA currently has the higher Sharpe Ratio (1.20 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.